Results 61 to 70 of about 54,491 (199)

Letters to the Editor [PDF]

open access: yes, 2011
Letter to the Editor, Jefferson Journal of Psychiatry, Volume 10, Number 1 ...

core   +1 more source

Anticorpos antinucleossomo e síndrome antifosfolipídica: estudo observacional Antinucleosome antibodies and primary antiphospholipid syndrome: an observational study

open access: yesRevista Brasileira de Reumatologia, 2012
OBJETIVO: Avaliar a associação entre a presença de anticorpos antinucleossomo (anti-NCS) e a síndrome antifosfolipídica primária (SAFP) e o posterior desenvolvimento de lúpus eritematoso sistêmico (LES).
Alexandre Wagner Silva de Souza   +4 more
doaj   +1 more source

Cyclosporine treatment of acquired hemophilia due to factor VIII antibodies [PDF]

open access: yes, 2000
Acquired hemophilia, caused by autoantibodies against coagulation factor VIII, is usually treated with steroids, cyclophosphamide, intravenous gammaglobulins and sporadically other drugs.
Baele, Gaston   +2 more
core  

Activation of Endothelial Cells by Antiphospholipid Antibodies—A Possible Mechanism Triggering Thrombosis in Patients with Antiphospholipid Syndrome [PDF]

open access: yes, 2006
Antiphospholipid syndrome (APS) is an antibody-mediated hypercoagulable state characterized by recurrent venous and arterial thromboembolic events. The presence of serum antibodies are collectively termed as antiphospholipid antibodies (aPL) and is the ...
Chen, Pei-Pei   +7 more
core   +2 more sources

36-Year-Old Female with Catastrophic Antiphospholipid Syndrome Treated with Eculizumab: A Case Report and Review of Literature

open access: yesCase Reports in Hematology, 2014
Catastrophic antiphospholipid syndrome (CAPS) is a rare but potentially life-threatening condition characterized by diffuse vascular thrombosis, leading to multiple organ failure developing over a short period of time in the presence of positive ...
Marianna Strakhan   +5 more
doaj   +1 more source

Antiphospholipid antibodies: Paradigm in transition [PDF]

open access: yes, 2009
OBJECTIVES: This is a critical review of anti-phospholipid antibodies (aPL). Most prior reviews focus on the aPL syndrome (APS), a thrombotic condition often marked by neurological disturbance.
Alireza Minagar   +9 more
core   +2 more sources

Emicizumab-Induced Seronegative Full-House Lupus Nephritis in a Child

open access: yesPediatrics, 2020
Hemophilia A (HA) is a serious inherited bleeding disorder resulting from a deficiency of coagulation factor VIII (FVIII). Replacement therapy with intravenous infusion of FVIII can be associated with treatment failure in approximately one-third of ...
H. Chehade   +8 more
semanticscholar   +1 more source

Comparative analysis of chromogenic vs clot based CDC modified, Nijmegen-Bethesda assay for detection of factor viii inhibitor titre [PDF]

open access: yes, 2020
Background:-Inhibitors to infused factor VIII are the most significant complication of hemophilia treatment. These inhibitors are usually IgG antibodies, that react with FVIII in a time and temperature dependent manner. Coagulation factor VIII inhibitors
Baig, Mirza Asif   +4 more
core   +2 more sources

Mass-conserving weak solutions to Oort-Hulst-Safronov coagulation equation with singular rates [PDF]

open access: yesarXiv, 2020
Existence of global weak solutions to the continuous Oort-Hulst-Safronov (OHS) coagulation equation is investigated for coagulation kernels capturing a singularity near zero and growing linearly at infinity. The proof mainly relies on a relation, between classical Smoluchowski coagulation equation (SCE) and OHS coagulation equation, which is introduced
arxiv  

Ruling out lupus anticoagulants with mixing test–specific cutoff assessment and the index of circulating anticoagulant

open access: yesResearch and Practice in Thrombosis and Haemostasis, 2019
Background Lupus anticoagulant (LA) is classified in the antibody family that is recognized in antiphospholipid syndrome. Mixing tests are recommended for LA detection, and either a mixing test–specific cutoff (MTC) or index of circulating anticoagulant (
Osamu Kumano, Gary W. Moore
doaj   +1 more source

Home - About - Disclaimer - Privacy